Cargando…

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes

AIM: The aim of this study is to evaluate the efficacy of 2% rebamipide ophthalmic solution on the tear functions and ocular surface status in patients with dry eyes. MATERIALS AND METHODS: A prospective study was carried out on forty eyes of patients having signs and symptoms of dry eye. Two percen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrivastava, Saurabh, Patkar, Priyanka, Ramakrishnan, Reshma, Kanhere, Minal, Riaz, Zahna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219330/ https://www.ncbi.nlm.nih.gov/pubmed/30505109 http://dx.doi.org/10.4103/ojo.OJO_29_2017

Ejemplares similares

Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
por: Ueda, Kaori, et al.
Publicado: (2015)

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
por: Kashima, Tomoyuki, et al.
Publicado: (2014)

Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre
por: Jain, Kalpna, et al.
Publicado: (2023)

Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice
por: Fu, Rongrong, et al.
Publicado: (2019)

The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress
por: Simsek, Cem, et al.
Publicado: (2019)

Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients
por: Sakane, Yuri, et al.
Publicado: (2019)

Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye
por: Igarashi, Tsutomu, et al.
Publicado: (2018)

Corrigendum to “Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients”
por: Sakane, Yuri, et al.
Publicado: (2020)

Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren’s syndrome-associated dry eyes
por: Shoji, Jun, et al.
Publicado: (2020)

Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
por: Eom, Youngsub, et al.
Publicado: (2023)

The Efficacy and Safety of Rebamipide Ophthalmic Suspension (OPC-12759) in Patients with Dry Eye Disease: A Systematic Review of Randomized Controlled Trials
por: Ballesteros-Sánchez, Antonio, et al.
Publicado: (2023)

Anterior ischemic optic neuropathy following dengue fever
por: Ramakrishnan, Reshma, et al.
Publicado: (2016)

Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes
por: Hayashi, Yusuke, et al.
Publicado: (2016)

The Effect of Rebamipide on Refractive Accuracy of Cataract Surgery in Patients with Dry Eye
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

The Efficacy of 2% Topical Rebamipide on Conjunctival Squamous Metaplasia and Goblet Cell Density in Dry Eye Disease
por: Simsek, Cem, et al.
Publicado: (2019)

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles
por: Nagai, Noriaki, et al.
Publicado: (2020)

Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
por: Fujimoto, Masahiro, et al.
Publicado: (2014)

Alkali Burn Treated with 2% Rebamipide Ophthalmic Suspension: A Case Report
por: Sasaki, Hidenori, et al.
Publicado: (2014)

Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
por: Karpecki, Paul, et al.
Publicado: (2023)

Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: a Japanese Phase II clinical trial
por: Toshida, Hiroshi, et al.
Publicado: (2017)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
por: de Oliveira, Rodrigo Carlos, et al.
Publicado: (2019)

Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum]
Publicado: (2021)

Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy
por: Godin, Morgan R, et al.
Publicado: (2017)

Impact of Perioperative Dry Eye Treatment with Rebamipide Versus Artificial Tears on Visual Outcomes After Cataract Surgery in Japanese Population
por: Teshigawara, Takeshi, et al.
Publicado: (2022)

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
por: Nguyen, Theresa, et al.
Publicado: (2011)

Effects of Rebamipide on Differences in Power and Axis of Corneal Astigmatism Between Two Intra-patient Keratometric Measurements in Dry Eyes
por: Teshigawara, Takeshi, et al.
Publicado: (2021)

Case Report: A Rare Orbital Abscess Caused by Dacryocystitis After Administration of Rebamipide Ophthalmic Suspension
por: Imamura, Hitoshi, et al.
Publicado: (2021)

Improvement of Evaporative Dry Eye With Meibomian Gland Dysfunction in Model Mice by Treatment With Ophthalmic Solution Containing Mineral Oil
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Effectiveness of hyaluronic acid and arnica extract ophthalmic solution in reducing dry eye symptoms in pediatric population
por: Buzzonetti, Luca, et al.
Publicado: (2022)

Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens
por: Yang, Yuanfang, et al.
Publicado: (2023)

Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye
por: Meerovitch, Karen, et al.
Publicado: (2013)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
por: Burade, Vinod, et al.
Publicado: (2020)

Irrational ophthalmic fixed-dose combinations for dry eye syndrome
por: Kshirsagar, Nilima A, et al.
Publicado: (2022)

Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections
por: Miller, Darlene
Publicado: (2008)

Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution
por: Ishikawa, Sho, et al.
Publicado: (2023)

Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms
por: Mizukami, Kazuhiro, et al.
Publicado: (2012)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
por: Matossian, Cynthia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kc6807dls8bcbs4lj9h563o5au